16
Participants
Start Date
August 31, 2013
Primary Completion Date
May 31, 2016
Study Completion Date
May 31, 2016
Bendamustine
Route of administration: intravenously (IV) over approximately 60 minutes, days 1-5.
Clofarabine
Route of administration: IV days 1-5.
Etoposide
Route of administration: IV days 1-5.
Etoposide phosphate
Route of administration: Used in substitution for etoposide in participants who experience allergic reaction, Etopophos® will be administered IV.
Dexamethasone
Route of administration: three times daily orally (by mouth), days 1-5.
St. Jude Children's Research Hospital, Memphis
Teva Pharmaceuticals USA
INDUSTRY
St. Jude Children's Research Hospital
OTHER